Holen Sie sich die Stockscreener-App
7.09
22.24%
1.29
Handel nachbörslich:
6.80
-0.29
-4.09%
Schlusskurs vom Vortag:
$5.80
Offen:
$5.88
24-Stunden-Volumen:
297.69K
Relative Volume:
0.97
Marktkapitalisierung:
$120.22M
Einnahmen:
$53.74M
Nettoeinkommen (Verlust:
$33.24M
KGV:
2.6622
EPS:
2.6632
Netto-Cashflow:
$-27.40M
1W Leistung:
+16.80%
1M Leistung:
+13.99%
6M Leistung:
+244.17%
1J Leistung:
+337.65%
1-Tages-Spanne:
$5.81
$7.26
1-Wochen-Bereich:
$5.375
$7.26
52-Wochen-Spanne:
$1.345
$8.045
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
7.09 | 98.35M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
This Q32 Bio analyst begins coverage on a bullish note; here are top 3 initiations for Friday - MSN
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
Mizuho initiates Q32 Bio stock coverage with Outperform rating - Investing.com UK
QTTB | Q32 Bio Inc. Common Analyst Forecasts - Quiver Quantitative
Mizuho initiates Q32 Bio stock coverage with Outperform rating By Investing.com - Investing.com Australia
Q32 BIO INC. (QTTB) - MSN
Q32 Bio gears up to report Q1 earnings: What's in the cards? - MSN
Point72 reports 958,768-share (5.7%) stake in Q32 Bio (QTTB) - Stock Titan
Sirenia and Alex Silverstein report 9.9% stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio (QTTB) Stock Price, News & Analysis - MarketBeat
Number of shareholders of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Number of shareholders of Q32 Bio Inc. – BOATS:QTTB - TradingView
The organic vs inorganic growth story at Q32 Bio (QTTB) | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - newser.com
QTTB SEC FilingsQ32 BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
QTTB Q32 Bio posts massive EPS beat, yet shares dip despite blowout quarter.Working Capital - newser.com
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - Yahoo Finance Singapore
How Q32 Bio (QTTB) guidance shapes future expectations | Q4 2025: Profit SurprisesBest Pick - newser.com
Why Q32 Bio (QTTB) might be the portfolio Builder you need (+6.42%) 2026-05-06Fundamentals - newser.com
OrbiMed updates Q32 Bio (QTTB) ownership at 13.3% of common stock - Stock Titan
Opaleye/James Silverman hold 8.59% of Q32 Bio (NASDAQ: QTTB) - Stock Titan
Q32 Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Q32 Bio: Q1 Earnings Snapshot - theheraldreview.com
Regulatory Compliance Risks: Q32 Bio Warns of Internal Control Challenges Under Sarbanes-Oxley and Potential Impact on Investors - TipRanks
Q32 Bio Inc. posts first quarter 2026 financial results and issues corporate update - Traders Union
Q32 Bio Inc. 1Q 2026: Net loss $(7.61M), EPS $(0.54) — 10-Q Summary - TradingView
Q32 Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q32 Bio (QTTB) narrows Q1 2026 loss and funds runway into 1H 2028 - Stock Titan
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Wells Fargo initiated coverage on Q32 Bio with a new price target - Quantisnow
Q32 Bio Inc expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards? - sharewise.com
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Q32 Bio (NASDAQ:QTTB) Trading Down 3.8%What's Next? - MarketBeat
QTTB (Q32 Bio) posts massive Q4 2025 EPS beat, but shares drop 3.85 percent amid investor uncertainty.Market Buzz Alerts - newser.com
Q32 Bio Expands ATM Offering With New $75M Prospectus - The Globe and Mail
QTTB Price Today: Q32 Bio Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Q32 Bio files prospectus for up to $75 million at-the-market share offering - Investing.com UK
Q32 Bio Inc files additional prospectus to offer up to $75 million of common stock - marketscreener.com
Q32 Bio files $75M prospectus supplement after exhausting $14.2M ATM offering - TradingView
Q32 Bio (QTTB) Stock: Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesRisk Event - Cổng thông tin điện tử tỉnh Lào Cai
Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesPro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Q32 Bio (QTTB) Stock Insider Ownership (Bearish Sentiment) 2026-04-22Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Q32 Bio (QTTB) Stock: Buy Decision Breakdown (Bullish Sentiment) 2026-04-20Blue Chip Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Pullback Watch: Will Q32 Bio Inc benefit from geopolitical trendsStop Loss & Stock Portfolio Risk Management - baoquankhu1.vn
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Q 32 Bio Inc-Aktie (QTTB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morrison Jodie Pope | CEO |
Feb 25 '26 |
Sale |
4.51 |
9,896 |
44,675 |
89,104 |
| Violette Shelia M. | Chief Scientific Officer |
Feb 25 '26 |
Sale |
4.51 |
2,815 |
12,708 |
55,569 |
| Morrison Jodie Pope | CEO |
Dec 02 '25 |
Sale |
3.46 |
22,506 |
77,871 |
99,000 |
| Kalowski Lee | CFO and President |
Dec 02 '25 |
Sale |
3.46 |
9,072 |
31,395 |
39,938 |
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):